Similar articles

• [Sustained levodopa efficacy in parkinsonism. Results of a four-year long-term follow-up study (author's transl)].

  Schneider E, Fischer PA, Jacobi P. Schneider E, et al. Nervenarzt. 1977 Apr;48(4):205-10. Nervenarzt. 1977. PMID: 404579 German. No abstract available.
• [L-dopa + peripheral decarboxylase antagonist].

  Wiesel FA. Wiesel FA. Lakartidningen. 1975 Oct 22;72(43):4173. Lakartidningen. 1975. PMID: 1177632 Swedish. No abstract available.
• [The problem of side effects after a treatment with L-dopa in the Parkinson's syndrome: clinical and animal studies (author's transl)].

  Sommer H, Fischer GJ, Quandt J. Sommer H, et al. Folia Clin Int (Barc). 1974 Oct;24(10):681-95. Folia Clin Int (Barc). 1974. PMID: 4279185 Spanish. No abstract available.
• [Progress in therapy of Parkinsonian syndrome].

  Völler GW. Völler GW. Hippokrates. 1975 Feb;46(1):17-33. Hippokrates. 1975. PMID: 1091605 Review. German. No abstract available.
• Levodopa treatment of Parkinson's syndrome: past and future.

  Pletscher A. Pletscher A. Adv Neurol. 1990;53:469-73. Adv Neurol. 1990. PMID: 2239486 Review. No abstract available.